What is he best known for?
The fields of study he is best known for:
- Dopamine
- Internal medicine
- Pharmacology
Richard B. Rothman focuses on Pharmacology, Dopamine, Internal medicine, Endocrinology and Agonist.
His Pharmacology research is multidisciplinary, incorporating perspectives in Amphetamine, Monoamine neurotransmitter, Fenfluramine, Serotonin and Neurochemical.
His Dopamine research incorporates elements of Reuptake inhibitor and MDMA.
He works mostly in the field of Endocrinology, limiting it down to topics relating to Methamphetamine and, in certain cases, Mephedrone, Bath salts, Methylenedioxypyrovalerone and Methylone.
His biological study spans a wide range of topics, including Stimulation, Stereochemistry and Opioid.
His study looks at the intersection of Opioid and topics like Morphine with Opioid peptide.
His most cited work include:
- Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. (761 citations)
- A proposal for the classification of sigma binding sites. (675 citations)
- Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist (597 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Pharmacology, Stereochemistry, Dopamine, Internal medicine and Endocrinology.
His Pharmacology research includes themes of Amphetamine, Neurochemical and Fenfluramine, Serotonin.
His Serotonin study combines topics in areas such as Norepinephrine, Neurotoxicity, MDMA and Neurotransmitter.
His research in Stereochemistry intersects with topics in Agonist, Receptor, Opioid receptor, Chemical synthesis and Binding site.
His Dopamine study combines topics from a wide range of disciplines, such as Monoamine neurotransmitter and Biogenic amine.
The Endocrinology study combines topics in areas such as Neuropeptide and Opiate.
He most often published in these fields:
- Pharmacology (41.36%)
- Stereochemistry (36.25%)
- Dopamine (26.76%)
What were the highlights of his more recent work (between 2006-2019)?
- Pharmacology (41.36%)
- Dopamine (26.76%)
- Stereochemistry (36.25%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pharmacology, Dopamine, Stereochemistry, Serotonin and Agonist.
His Pharmacology research incorporates themes from Microdialysis, Monoamine neurotransmitter, Fenfluramine and Opioid.
His Dopamine study often links to related topics such as Stimulant.
The study incorporates disciplines such as Receptor, Opioid receptor, Chemical synthesis and Stereoisomerism in addition to Stereochemistry.
His studies in Serotonin integrate themes in fields like Endocrinology and Neurotransmitter.
His Agonist research is multidisciplinary, incorporating elements of Molecule, Serotonin Agents, Antagonist and Mechanism of action.
Between 2006 and 2019, his most popular works were:
- The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue (322 citations)
- Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. (292 citations)
- Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic Mice (244 citations)
In his most recent research, the most cited papers focused on:
- Dopamine
- Internal medicine
- Pharmacology
His main research concerns Pharmacology, Dopamine, Monoamine neurotransmitter, Agonist and Serotonin.
His studies deal with areas such as Fenfluramine and Opioid as well as Pharmacology.
His Dopamine research is multidisciplinary, relying on both Addiction and Stimulant.
His study on Norepinephrine reuptake inhibitor is often connected to Quetiapine Fumarate as part of broader study in Serotonin.
He has researched Opioid receptor in several fields, including Arrestin and Stereochemistry.
Within the field of Endocrinology and Internal medicine Richard B. Rothman studies Superoxide dismutase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
